Stay updated on CMP-001 with Pembrolizumab: Clinical Trial
Sign up to get notified when there's something new on the CMP-001 with Pembrolizumab: Clinical Trial page.

Latest updates to the CMP-001 with Pembrolizumab: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry 'Revision: v3.4.2' to the record history. Removed the older notices including the funding-related message and 'Revision: v3.4.1'.SummaryDifference0.6%

- Check21 days agoChange DetectedA site-wide notice about government funding status was added, and the revision version updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check28 days agoChange Detected- The page now displays a Record History with Study Record Versions, showing past and current changes to the trial record (e.g., IPDSharing, Conditions, Study Design). - Additions and deletions are color-coded to indicate what changed.SummaryDifference26%

- Check42 days agoChange DetectedThe revision label on the page changed from v3.3.3 to v3.3.4, a minor update to the site revision without altering study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page history now shows a new site revision: Revision: v3.3.3, and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2. These are site-wide updates rather than changes to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedOnly the revision label was updated from v3.3.1 to v3.3.2; no other content appears changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CMP-001 with Pembrolizumab: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 with Pembrolizumab: Clinical Trial page.